Mucker E, Shamblin J, Goff A, Bell T, Reed C, Twenhafel N
Viruses. 2022; 14(9).
PMID: 36146799
PMC: 9505131.
DOI: 10.3390/v14091993.
Forsyth K, DeHaven B, Mendonca M, Paul S, Sette A, Eisenlohr L
J Immunol. 2019; 202(5):1340-1349.
PMID: 30700590
PMC: 6394857.
DOI: 10.4049/jimmunol.1801099.
Meseda C, Campbell J, Kumar A, Garcia A, Merchlinsky M, Weir J
PLoS One. 2013; 8(6):e67984.
PMID: 23785523
PMC: 3681963.
DOI: 10.1371/journal.pone.0067984.
Golden J, Hooper J
Expert Rev Vaccines. 2011; 10(7):1021-35.
PMID: 21806397
PMC: 9491137.
DOI: 10.1586/erv.11.46.
Nelson G, Sisler J, Chandran D, Moss B
Virology. 2008; 380(2):394-401.
PMID: 18789472
PMC: 2628551.
DOI: 10.1016/j.virol.2008.08.009.
Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.
Fogg C, Americo J, Earl P, Resch W, Aldaz-Carroll L, Eisenberg R
J Virol. 2008; 82(16):8022-9.
PMID: 18524827
PMC: 2519570.
DOI: 10.1128/JVI.00568-08.
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
Xu R, Cohen M, Tang Y, Lazear E, Whitbeck J, Eisenberg R
J Exp Med. 2008; 205(4):981-92.
PMID: 18391063
PMC: 2292233.
DOI: 10.1084/jem.20071854.
Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.
Garcia A, Meseda C, Mayer A, Kumar A, Merchlinsky M, Weir J
Clin Vaccine Immunol. 2007; 14(8):1032-44.
PMID: 17596428
PMC: 2044493.
DOI: 10.1128/CVI.00050-07.
Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
Chen Z, Earl P, Americo J, Damon I, Smith S, Yu F
J Virol. 2007; 81(17):8989-95.
PMID: 17581986
PMC: 1951440.
DOI: 10.1128/JVI.00906-07.
B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.
Viner K, Girgis N, Kwak H, Isaacs S
Virology. 2006; 361(2):356-63.
PMID: 17188733
PMC: 2048764.
DOI: 10.1016/j.virol.2006.11.020.
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
Chen Z, Earl P, Americo J, Damon I, Smith S, Zhou Y
Proc Natl Acad Sci U S A. 2006; 103(6):1882-7.
PMID: 16436502
PMC: 1413659.
DOI: 10.1073/pnas.0510598103.
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
Fogg C, Lustig S, Whitbeck J, Eisenberg R, Cohen G, Moss B
J Virol. 2004; 78(19):10230-7.
PMID: 15367588
PMC: 516428.
DOI: 10.1128/JVI.78.19.10230-10237.2004.
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.
Zhang W, Wilcock D, Smith G
J Virol. 2000; 74(24):11654-62.
PMID: 11090164
PMC: 112447.
DOI: 10.1128/jvi.74.24.11654-11662.2000.
Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.
Lorenzo M, Galindo I, Griffiths G, Blasco R
J Virol. 2000; 74(22):10535-50.
PMID: 11044098
PMC: 110928.
DOI: 10.1128/jvi.74.22.10535-10550.2000.
Using confocal microscopy to study virus binding and entry into cells.
Vanderplasschen A, Smith G
Methods Enzymol. 1999; 307:591-607.
PMID: 10506996
PMC: 7172951.
DOI: 10.1016/s0076-6879(99)07035-4.
Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.
Roper R, Moss B
J Virol. 1999; 73(2):1108-17.
PMID: 9882312
PMC: 103931.
DOI: 10.1128/JVI.73.2.1108-1117.1999.
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.
Vanderplasschen A, Mathew E, Hollinshead M, Sim R, Smith G
Proc Natl Acad Sci U S A. 1998; 95(13):7544-9.
PMID: 9636186
PMC: 22678.
DOI: 10.1073/pnas.95.13.7544.
The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
Roper R, Wolffe E, WEISBERG A, Moss B
J Virol. 1998; 72(5):4192-204.
PMID: 9557708
PMC: 109648.
DOI: 10.1128/JVI.72.5.4192-4204.1998.
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.
Vanderplasschen A, Smith G
J Virol. 1997; 71(5):4032-41.
PMID: 9094681
PMC: 191556.
DOI: 10.1128/JVI.71.5.4032-4041.1997.
Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene.
Roper R, Payne L, Moss B
J Virol. 1996; 70(6):3753-62.
PMID: 8648710
PMC: 190251.
DOI: 10.1128/JVI.70.6.3753-3762.1996.
